Published in J Comput Assist Tomogr on August 25, 1987
Brain tumors. West J Med (1991) 1.44
Differentiation of glioma and radiation injury in rats using in vitro produce magnetically labeled cytotoxic T-cells and MRI. PLoS One (2010) 0.93
Pathophysiology, diagnosis, and treatment of radiation necrosis in the brain. Neurol Med Chir (Tokyo) (2014) 0.93
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging (2013) 0.86
Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression. J Neuroimaging (2010) 0.85
Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma. Eur Radiol (2013) 0.83
3'-Deoxy-3'-[(18)F]fluorothymidine and O-(2-[(18)F]fluoroethyl)-L-tyrosine PET in Patients with Suspicious Recurrence of Glioma after Multimodal Treatment: Initial Results of a Retrospective Comparative Study. Nucl Med Mol Imaging (2010) 0.80
Comparative study of (18)F-DOPA, (13)N-Ammonia and F18-FDG PET/CT in primary brain tumors. Indian J Nucl Med (2011) 0.79
Positron emission tomography and the central nervous system. Arch Dis Child (1999) 0.75
Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape. J Neurooncol (2017) 0.75
In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats. Mol Imaging Biol (2017) 0.75
Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol (1999) 8.69
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer (2000) 4.96
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. Neurology (2009) 3.68
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol (1999) 3.30
Time-of-flight positron emission tomography: status relative to conventional PET. J Nucl Med (1983) 3.08
Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology (2000) 3.03
Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp Neurol (2000) 2.98
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene (2000) 2.81
Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg (1977) 2.39
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. J Clin Oncol (2000) 2.22
Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci U S A (2000) 2.08
Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst (2001) 2.06
Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem (1980) 2.01
Electromagnetic fields of surface coil in vivo NMR at high frequencies. Magn Reson Med (1991) 1.88
Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease. Magn Reson Med (1988) 1.87
Surgical treatment of syringomyelia. Favorable results with syringoperitoneal shunting. J Neurosurg (1984) 1.84
An integrated functional magnetic resonance imaging procedure for preoperative mapping of cortical areas associated with tactile, motor, language, and visual functions. Neurosurgery (2000) 1.83
Germline p53 gene mutations in subsets of glioma patients. J Natl Cancer Inst (1994) 1.81
Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. J Comput Assist Tomogr (1983) 1.77
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1998) 1.71
Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys (1994) 1.70
Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol (2000) 1.66
Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery (1998) 1.66
Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study. J Clin Oncol (1991) 1.60
Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study. Int J Radiat Oncol Biol Phys (1991) 1.59
Kinetic analysis of 125I-iodorotenone as a deposited myocardial flow tracer: comparison with 99mTc-sestamibi. J Nucl Med (2001) 1.58
Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys (1990) 1.57
Response and progression in recurrent malignant glioma. Neuro Oncol (1999) 1.57
Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys (1996) 1.56
Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. J Nucl Med (1992) 1.50
Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys (1999) 1.50
Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery (1987) 1.49
Pineal region tumors in children. J Neurosurg (1988) 1.47
Does chemotherapy benefit the patient with a central nervous system glioma? Oncology (Williston Park) (1987) 1.47
Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol (1997) 1.47
Suppression of human glioma growth by adenovirus-mediated Rb gene transfer. Neurology (1998) 1.46
NMR of laser-polarized xenon in human blood. Proc Natl Acad Sci U S A (1996) 1.46
The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. Int J Radiat Oncol Biol Phys (1995) 1.45
Emission computer assisted tomography with single-photon and positron annihilation photon emitters. J Comput Assist Tomogr (1977) 1.44
Gamma knife radiosurgery in children. Pediatr Neurosurg (1996) 1.43
Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg (1996) 1.36
Nuclear magnetic resonance (NMR) in vivo studies: known thresholds for health effects. J Comput Assist Tomogr (1981) 1.35
Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys (1994) 1.34
Sucrose and inulin space measurements of cerebral cortex in four mammalian species. Am J Physiol (1970) 1.32
Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys (1989) 1.31
Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry (1985) 1.30
Pathological and positron emission tomographic correlations in Alzheimer's disease. Lancet (1985) 1.29
Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology (1988) 1.28
Analytical decision model for the cost-effective management of solitary pulmonary nodules. J Clin Oncol (1998) 1.27
Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. J Neurosurg (1986) 1.26
Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol (1998) 1.25
External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys (1997) 1.25
Corticosteroid therapy in patients with brain tumors. Natl Cancer Inst Monogr (1977) 1.24
The diagnosis of dementia with single photon emission computed tomography. Arch Neurol (1987) 1.21
Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res (1996) 1.21
Factors influencing the survival of rat brain tumor cells after in vitro treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res (1975) 1.21
Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery (2000) 1.20
Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat Med (1998) 1.18
Complications of anterior skull base surgery. Skull Base Surg (1996) 1.18
Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery (1987) 1.18
High-resolution (2.6-mm) PET in partial complex epilepsy associated with mesial temporal sclerosis. Radiology (1993) 1.17
Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. Oncogene (1991) 1.15
Craniofacial resection for malignant tumors involving the anterior skull base. Arch Otolaryngol Head Neck Surg (1997) 1.15
Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential. Amino Acids (2007) 1.14
Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys (1997) 1.14
Cerebrospinal fluid production by the choroid plexus and brain. Science (1971) 1.14
Activity of pp60c-src in 60 different cell lines derived from human tumors. Cancer Biochem Biophys (1994) 1.13
Age-related chemosensitivity of stem cells from human malignant brain tumours. Lancet (1982) 1.13
In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg (1986) 1.12
Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid. Clin Cancer Res (1996) 1.12
The 9L rat brain tumor: description and application of an animal model. J Neurol (1981) 1.11
Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys (1996) 1.11
Disposal of blood [1-13C]lactate in humans during rest and exercise. J Appl Physiol (1985) (1986) 1.11
Interstitial irradiation of brain tumors: a review. Neurosurgery (1981) 1.11
Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg (1991) 1.11
Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep (1980) 1.09
Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer (1997) 1.09
Use of MR spectroscopy and functional imaging in the treatment planning of gliomas. Br J Radiol (2006) 1.07
Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia. J Neurol Neurosurg Psychiatry (1985) 1.07
Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis. J Natl Cancer Inst (1997) 1.07
18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer (1997) 1.07
Stereotaxic irradiation of brain tumors. Cancer (1990) 1.07
Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer. Int J Radiat Oncol Biol Phys (1979) 1.06
Measurement of 129Xe T1 in blood to explore the feasibility of hyperpolarized 129Xe MRI. J Comput Assist Tomogr (1996) 1.06
Factors associated with false-positive staging of lung cancer by positron emission tomography. Ann Thorac Surg (2000) 1.06
Diminished glucose transport in Alzheimer's disease: dynamic PET studies. J Cereb Blood Flow Metab (1991) 1.06
Evaluation of malignant glioma patients during the postirradiation period. J Neurosurg (1979) 1.06
Brain function and cognition in a community sample of elderly Latinos. Neurology (2002) 1.05
Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources. J Neurosurg (1987) 1.05
Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett (1985) 1.05
Instrumentation trends in nuclear medicine. Semin Nucl Med (1977) 1.04
Multipole shimming of permanent magnets using harmonic corrector rings. Rev Sci Instrum (2007) 1.03
Methotrexate pneumonitis induced by intrathecal methotrexate therapy: a case report with pharmacokinetic data. Cancer (1976) 1.03
Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors. Cancer (1989) 1.03
Radiosurgery for hemangioblastoma: results of a multiinstitutional experience. Int J Radiat Oncol Biol Phys (1996) 1.02